Lin-Chau Chang

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Drug Administration

Epidermal Growth Factor Receptor

Health Information

Top Venues

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ching-An Cheng, Ai-Lei Jiang, Yu-Ru Liu, Lin-Chau Chang
Investigation of immunogenicity assessment of biosimilar monoclonal antibodies in the United States. Clinical pharmacology and therapeutics (2023)
Jhih-Wei Huang, Ching-Hua Kuo, Han-Chun Kuo, Jin-Yuan Shih, Teng-Wen Tsai, Lin-Chau Chang
Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel. PloS one 16 (3) (2021)
Ai-Lei Jiang, Christopher D Breder, Lin-Chau Chang
Investigation of Factors Associated With Immunogenicity Labeling Updates and Characteristics of Biologics License Applications. Clinical pharmacology and therapeutics 110 (5) (2021)